International Business News - IDEV http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the stock activity stories for Tuesday, Nov. 25, from AP Financial News: NEW YORK (AP)--Shares of ConAgra Foods Inc. fell more than 4 percent on Tuesday as sales volume data showed softening as it faces greater competition for frozen food sales. http://www.ibtimes.com/articles/20081125/movers-roundup-conagra-ariba.htm Tue, 25 Nov 2008 14:45:36 EST Shares of Indevus Pharmaceuticals Inc. gained ground Tuesday after the company said it would resubmit an application for approval of its developing horomonal treatment Nebido by the end of March, with seemingly better safety data. http://www.ibtimes.com/articles/20081125/indevus-shares-jump-on-prospects-for-drug-filing.htm Tue, 25 Nov 2008 12:34:10 EST Among the stock activity stories for Friday, Sept. 26, from AP Financial News: WASHINGTON (AP)--Shares of F5 Networks were up nearly 6 percent Friday after two analysts upgraded the stock, saying that recent concerns about the company's exposure to the crisis on Wall Street are overblown. http://www.ibtimes.com/articles/20080926/movers-roundup-f5-networks-wachovia.htm Fri, 26 Sep 2008 14:41:57 EDT Shares of Indevus Pharmaceuticals Inc. more than doubled Friday after the company said it is collaborating with Teva Pharmaceutical Industries Ltd. to develop a treatment for stuttering and could move forward with its delayed horomonal disorder drug. http://www.ibtimes.com/articles/20080926/indevus-shares-double-deals-with-fda-teva.htm Fri, 26 Sep 2008 19:24:01 EDT Indevus Pharmaceuticals said Wednesday the drug Sanctura XR, which is used to treat overactive bladder, has received nearly 17 years worth of patent protection in the U.S. http://www.ibtimes.com/articles/20080813/indevus-says-bladder-treatment-gets-us-patent.htm Wed, 13 Aug 2008 17:47:02 EDT Shares of Indevus Pharmaceuticals Inc. rose Monday after drug developer said the Food and Drug Administration gave it clear recommendations to put an experimental testosterone drug back on the path toward approval. http://www.ibtimes.com/articles/20080630/indevus-shares-rise-on-nebido-cost-cutting-plan.htm Mon, 30 Jun 2008 20:14:18 EDT Drug developer Indevus Pharmaceuticals Inc. said Thursday that Chairman and Chief Executive Glenn L. Cooper is postponing his retirement as a result of a delay in the company's injectable testosterone drug candidate. http://www.ibtimes.com/articles/20080612/indevus-chief-executive-postpones-retirement-plans.htm Thu, 12 Jun 2008 11:29:24 EDT Among the stock activity stories for Wednesday, June 4, from AP Financial News: NEW YORK (AP)--Shares of First Horizon National Corp. rose Wednesday as the regional bank agreed to sell its residential mortgage business to a subsidiary of MetLife Inc. http://www.ibtimes.com/articles/20080604/movers-roundup-first-horizon-prestige-brands.htm Wed, 04 Jun 2008 14:28:03 EDT Shares of Indevus Pharmaceuticals Inc. plunged Wednesday after the company said its injectable testosterone drug candidate will face a regulatory delay of up to two years with the Food and Drug Administration because of safety concerns. http://www.ibtimes.com/articles/20080604/indevus-shares-plunge-on-testosterone-drug-delay.htm Wed, 04 Jun 2008 19:47:56 EDT